Here, we aimed to use brain tumor-related epigenetic signatures to understand isocitrate dehydrogenase (IDH)-wild-type high-grade gliomas, suggesting that certain epigenetic subclasses may be more likely to be integrated into neuron-to-glioma networks with clinical relevance. Here, IDH3A is linked to central nervous system cancer.